Using biological processes to effectively target cancer and infectious disease with Esphera SynBio
Esphera SynBio, a synthetic biology platform is reprogramming the human body’s own communication system to deliver new cancer and infectious disease therapeutics, a solution with the power to impact many lives.
Recent awards power two new studies into drug discovery and development
Kapoose Creek Bio is working with McMaster University for drug discovery and development to innovate treatments for neurological conditions.
Leading the new era of AI-driven drug discovery with Stoked Bio
Discover how Stoked Bio is leveraging resources like the SOPHIE program to advance AI-driven drug discovery.
Advancing Stroke Rehabilitation with IRegained’s MyHand® System
Explore how IRegained leveraged resources like the CAMEDA program to advance their MyHand® System for stroke rehabilitation
New life science products and services launch through support from Innovation Factory
Discover how the SOPHIE commercialization program and CAMEDA grants have helped life sciences startups succeed.
Innovation Factory’s SOPHIE Program secures three-year renewal with $5.2M investment
Minister Tassi announces $5M Government of Canada investment into SOPHIE program renewal to support Canadian life sciences innovation.
Improving patient recovery with FluidAI’s postoperative monitoring solution
Learn about how FluidAI Medical’s postoperative monitoring solution is leveraging AI to detect anastomotic leaks and improve recovery times.
Innovation Factory fosters life science success stories in Ontario through SOPHIE program
Since 2021, Innovation Factory’s SOPHIE program has helped support the growth of over 160 innovative Ontario life science companies.
Healing chronic wounds with Swift Medical
Learn how Swift Medical is reshaping the way wounds are imaged for diagnosis with AI and data-driven technology.
Synmedix: Treating infections with the next generation of antibiotics
Discover how Synmedix is combating antibiotic resistance with support from the SOPHIE program and Synapse Life Science Competition.
Verv Technologies receives $100,000 from CAMEDA to accelerate commercial readiness of low-cost, high-quality blood analyzer
As a CAMEDA recipient, Verv Technologies will be collaborating with InertiaPD to advance key aspects of its technology platform.
Innovation Factory celebrates Hamilton’s growing life sciences network and SOPHIE program recipients
The Molecules and Masterpieces event showcased the SOPHIE program’s role as a catalyst for life science partnerships, commercialization and innovation.